This event, open to a wide range of stakeholders from academic researchers, funders to industry players and regulators, will bring together international experts to discuss the latest advancements in translational medicine.
The theme of this third edition, “Enhancing Predictivity in Medicines Development” will focus on bringing together the latest technologies to increase success in drug development, from novel in vitro systems to new biomarkers or clinical trial methodology for patient selection and stratification.
For this year’s edition, you will hear from – among others – Mark Schmidt (Senior Director, Janssen Research and Development), Philip Murphy (Head, Experimental Medicine Imaging, GSK), Christopher Austin (NIH-NCATS, United States). Find out all about the conference’s keynote speakers.
The programme also includes a pre-conference day on Sunday, September 24, that will be dedicated to a series of educational workshops tackling topics in the ﬁeld such as molecular imaging, biomarker validation or potency assays for ATMP’s and vaccines.
Translational Medicine 2017 also welcomes abstract submissions until May 15, 2017!
For more information, please visit: www.translationalmedicine2017.eu
Questions? Send an email to: email@example.com